TrialThe Journal of infectious diseases2017

An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults.

Judith Falloon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.